Under the National Tuberculosis Elimination Programme (NTEP), which regimen is currently recommended for drug-sensitive TB in adults who are NOT previously treated?
- A 2HRZE/4HR (Category I) under RNTCP
- B Daily regimen with 2HRZE/4HR under NTEP with fixed-dose combination tablets and treatment supporter ✓
- C Intermittent thrice-weekly DOTS for 6 months
- D BPaL regimen (bedaquiline, pretomanid, linezolid) for 6 months
Correct answer: B. Daily regimen with 2HRZE/4HR under NTEP with fixed-dose combination tablets and treatment supporter
Explanation
Under NTEP (which replaced RNTCP), daily fixed-dose combination (FDC) tablets have replaced the older intermittent DOTS regimens. The regimen is 2HRZE/4HR administered daily (not thrice weekly), with a treatment supporter and free medications under Ni-kshay. Intermittent DOTS is no longer the standard. BPaL is reserved for pre-XDR or XDR-TB. The shift from intermittent to daily therapy is a key NTEP update post-2020.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.